Mirna Therapeutics First to Advance MicroRNA Into Cancer Clinic Treatment

A leading Texas biotechnology company, Mirna Therapeutics, Inc. has announced the initiation of Phase 1 clinical trials of MRX34 in patients with unresectable primary liver cancer or metastatic cancer with liver involvement.

http://bionews-tx.com/news/2013/05/15/mirna-therapeutics-is-first-to-advance-microrna-into-the-clinic-for-cancer/

San Antonio-Based National Primate Research Center Findings Part Of Unlocking New microRNA Revelations

Read about how the San Antonio-Based National Primate Research Center Findings are Part Of Unlocking New microRNA Revelations

http://bionews-tx.com/news/2013/04/17/san-antonio-based-national-primate-research-center-findings-part-of-unlocking-new-microrna-revelations/